Individual Study / Prospective Study of Myocardial Infarction

Prospective Study of Myocardial Infarction

Prospective Study of Myocardial Infarction

Initiatives -
To assess prospectively the risk of myocardial infarction (Ml) associated with elevated levels of lipoprotein(a) (Lp[a]). *Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.*
Start Year
1981
Funding
National Institutes of Health

Members

Download
Investigators Contacts
  • Dr. Prof. Paul M. Ridker
    Harvard Medical School

Design

Study design
Case-control
Follow Up
Participants provided plasma samples at baseline and were followed up prospectively for an average period of 60.2 months.

Marker Paper

Ridker PM, Hennekens CH, Stampfer MJ. A Prospective Study of Lipoprotein(a) and the Risk of Myocardial Infarction. JAMA. 1993;270(18):2195–2199. doi:10.1001/jama.1993.03510180065035

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
14,916
Number of participants with biosamples
Supplementary Information
Male physicians aged 40 to 84 years with no prior history of Ml or stroke

Access

Availability of data and biosamples

Data
Biosamples
Other